Answer ALS: A Longitudinal Clinical and Biological Approach to Studying the Disease

Johns Hopkins neurologist Jeffrey Rothstein describes the personalized medicine initiative, Answer ALS, which gathered data points — both clinical and biological in nature — from over 1,000 patients with amyotrophic lateral sclerosis (ALS) who were followed in eight clinics across the United States. The data is available for free to researchers and commercial entities that are trying to better understand ALS and develop new treatments.

Created by

Johns Hopkins Medicine

Related Presenters

Jeffrey Rothstein, M.D., Ph.D.

Jeffrey Rothstein, M.D., Ph.D.

Dr. Jeffrey Rothstein focuses on neuromuscular diseases, with a particular focus on Amyotrophic lateral sclerosis (ALS). Other clinical areas relevant to his laboratory-based research include: idiopathic stupor, epilepsy and motor neuron degeneration.

View full profile